Pilot of Mailing Buprenorphine
ConditionOpioid Use Disorder
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedical University of South Carolina
About this trial
This pilot study evaluates the feasibility, acceptability, and preliminary effectiveness of mailing buprenorphine to individuals with opioid use disorder (OUD) following medical hospitalization. The intervention aims to improve retention in treatment by overcoming barriers such as transportation and pharmacy access.
Eligibility criteria
Qualifiers
Age ≥ 18
English-speaking
Diagnosed with OUD and initiated on buprenorphine during hospitalization
Discharging to a South Carolina address with a stable mailbox
Disqualifiers
Active psychosis or suicidal ideation
Severe medical or neurocognitive impairment
Pending incarceration
Trial design
Treatments tested in this trial
- strategy of mailing buprenorphine
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Medical University of South Carolina
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov